Fundz

Kiniksa Pharmaceuticals Appoints Ross Moat as President and COO

PUBLIC · KNSAOct 22, 2026
Internal move“Mr. Moat, who has been with the company since June 2019, previously served as the EVP, Chief Operating Officer.”

Position

President

Company

Kiniksa Pharmaceuticals, Ltd.

Ross Moat
BermudaBiotechnologyHealthcarePharmaceuticalBiopharma

Description

On October 17, 2026, Kiniksa Pharmaceuticals appointed Ross Moat as President and Chief Operating Officer, effective immediately. Mr. Moat, who has been with the company since June 2019, previously served as the EVP, Chief Operating Officer

Who to call at Kiniksa Pharmaceuticals, Ltd., and when

A new leader at Kiniksa Pharmaceuticals, Ltd. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kiniksa Pharmaceuticals, Ltd. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kiniksa Pharmaceuticals, Ltd., from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kiniksa Pharmaceuticals, Ltd.

Location

Clarendon House

Bermuda

About

Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kiniksa Pharmaceuticals, Ltd. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Kiniksa Pharmaceuticals, Ltd.'s next move

Learn about Strategic plan

Kiniksa Pharmaceuticals, Ltd. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.